We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLitigation Cap. Regulatory News (LIT)

Share Price Information for Litigation Cap. (LIT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 117.00
Bid: 116.50
Ask: 118.00
Change: 0.00 (0.00%)
Spread: 1.50 (1.288%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 117.00
LIT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Conclusion of Joint Venture Arrangement

20 Apr 2020 07:00

RNS Number : 1634K
Litigation Capital Management Ltd
20 April 2020
 

20 April 2020

 

 

Litigation Capital Management Limited

(LCM or the Company)

 

 

Conclusion of Joint Venture Arrangement

 

Litigation Capital Management Limited (AIM:LIT), a leading international provider of disputes financing solutions, announces the conclusion of its Joint Venture Arrangement (JVA or Arrangement) with Vannin Capital Limited (Vannin) and associated profit of A$2.45 million.

 

In 2013, LCM entered into a JVA with Vannin. That JVA involved LCM sourcing, negotiating and managing through to completion various litigation finance investments, all within Australia. Vannin supplied the capital associated with the Arrangement. In March 2015, the Arrangement went into runoff.

 

Whilst in runoff, certain disputes arose between the parties as to their entitlements. As part of the final resolution of those disputes, LCM will receive profits totalling A$2.45 million, contributing to LCM's gross profit for the current financial year. The JVA has now been concluded by all interested parties.

Patrick Moloney, CEO of LCM, commented: "We are very pleased to have come to a final resolution of the Joint Venture Arrangement, the amount received from which, exceeds our expectations."

 

Enquiries

 

Litigation Capital Management

c/o Alma PR 

Patrick Moloney, Chief Executive Officer

Canaccord (Nomad and Joint Broker) 

Tel: 020 7523 8000

Bobbie Hilliam

Investec Bank plc (Joint Broker)

Tel: 020 7597 5970

David Anderson

Alma PR

Tel: 020 3405 0205

Rebecca Sanders-Hewett

LCM@almapr.co.uk

Justine James

David Ison

 

 

NOTES TO EDITORS

 

Litigation Capital Management (LCM) is a global provider of disputes finance which operates two business models. The first is direct investments made from LCM's permanent balance sheet capital and the second is fund and/or asset management. Under those two business models, LCM currently pursues three investment strategies: Single-case funding, Corporate portfolio funding and Acquisitions of claims. LCM generates its revenue from both its direct investments and also performance fees through asset management.

LCM has an unparalleled track record, driven by effective project selection, active project management and robust risk management.

 

Headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.

 

www.lcmfinance.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
JVEIMMATMTATMIM
Date   Source Headline
29th Dec 20214:10 pmRNSDirector/PDMR Shareholding
17th Dec 20217:00 amRNSBoard change
10th Dec 202112:30 pmRNSIssue of Equity and Total Voting Rights
18th Nov 20217:00 amRNSResult of AGM
4th Nov 20217:00 amRNSSuccessful Award in LCIA International Arbitration
29th Oct 20211:24 pmRNSExercise of Options, Equity Issue, Director/PDMR
29th Oct 20211:00 pmRNSIncentive Awards
25th Oct 20217:00 amRNSNotice of AGM
18th Oct 202111:15 amRNSIssue of Equity and Total Voting Rights
14th Oct 20217:00 amRNSLCM Global Alternative Returns Fund II
22nd Sep 202111:20 amRNSHolding(s) in Company
21st Sep 20217:00 amRNSFinal Results 2021
31st Aug 20217:00 amRNSNotice of Results
11th Aug 20217:07 amRNSSuccessful judgment in Australian investment
19th Jul 20217:00 amRNSMarket Update
6th Jul 20217:00 amRNSNew Litigation Finance Agreement
23rd Jun 20217:00 amRNSComet Group liquidation claim
21st Jun 20217:21 amRNSJudgment in New Zealand Investment
27th May 20217:00 amRNSInvestor Presentation
19th May 20217:18 amRNSLitigation Finance Agreement with Carillion
4th May 202112:09 pmRNSHolding(s) in Company
14th Apr 20214:41 pmRNSSecond Price Monitoring Extn
14th Apr 20214:36 pmRNSPrice Monitoring Extension
16th Mar 20217:00 amRNSInterim Results
10th Mar 20216:07 pmRNSIssue of Equity and Total Voting Rights
10th Mar 20215:53 pmRNSHolding(s) in Company
25th Feb 20217:00 amRNSRetail Investor Presentation
22nd Feb 20217:00 amRNSNew US$50m Credit Facility
18th Feb 20212:30 pmRNSHolding(s) in Company
17th Feb 20217:00 amRNSNotice of Results
12th Feb 20215:13 pmRNSHolding(s) in Company
7th Jan 202111:20 amRNSHolding(s) in Company
17th Dec 202012:17 pmRNSHolding(s) in Company
19th Nov 20207:00 amRNSResult of AGM
28th Oct 20207:00 amRNSNotice of Annual General Meeting
15th Oct 202010:30 amRNSIncentive Awards
15th Oct 20207:00 amRNSHolding(s) in Company
23rd Sep 20204:26 pmRNSHolding(s) in Company
22nd Sep 20207:00 amRNSFinal Results
10th Sep 20202:57 pmRNSHolding(s) in Company
8th Sep 20207:00 amRNSNotice of Results
24th Aug 20207:00 amRNSFunding of Corporate Portfolio Transaction
18th Aug 20207:00 amRNSAppointment of Non-Executive Director
13th Aug 20207:16 amRNSDisputes Finance Facility with Global Law Firm
10th Jul 20207:04 amRNSMarket Update
6th Jul 20204:40 pmRNSSecond Price Monitoring Extn
6th Jul 20204:35 pmRNSPrice Monitoring Extension
2nd Jul 202010:42 amRNSBoard Updates
26th May 20207:00 amRNSAustralian Regulation of Litigation Funders
22nd May 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.